These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34470855)

  • 1. Long-Term Evolution of the Adaptive NKG2C
    Ataya M; Redondo-Pachón D; Llinàs-Mallol L; Yélamos J; Alari-Pahissa E; Pérez-Sáez MJ; Altadill M; Raïch-Regué D; Vilches C; Pascual J; Crespo M; López-Botet M
    J Immunol; 2021 Oct; 207(7):1882-1890. PubMed ID: 34470855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.
    Redondo-Pachón D; Crespo M; Yélamos J; Muntasell A; Pérez-Sáez MJ; Pérez-Fernández S; Vila J; Vilches C; Pascual J; López-Botet M
    J Immunol; 2017 Jan; 198(1):94-101. PubMed ID: 27913630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients.
    Ishiyama K; Arakawa-Hoyt J; Aguilar OA; Damm I; Towfighi P; Sigdel T; Tamaki S; Babdor J; Spitzer MH; Reed EF; Sarwal MM; Lanier LL;
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35181606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients.
    Ataya M; Redondo-Pachón D; Llinàs-Mallol L; Yélamos J; Heredia G; Pérez-Sáez MJ; Vila J; Costa-García M; Raïch-Regué D; Vilches C; Pascual J; Crespo M; López-Botet M
    Am J Transplant; 2020 Mar; 20(3):663-676. PubMed ID: 31612635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.
    Calabrese DR; Chong T; Wang A; Singer JP; Gottschall M; Hays SR; Golden JA; Kukreja J; Lanier LL; Tang Q; Greenland JR
    Transplantation; 2019 Mar; 103(3):493-501. PubMed ID: 30211828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
    Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
    J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
    Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D
    J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
    Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
    J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
    Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
    J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2C
    Grutza R; Moskorz W; Senff T; Bäcker E; Lindemann M; Zimmermann A; Uhrberg M; Lang PA; Timm J; Cosmovici C
    J Immunol; 2020 Jun; 204(11):2910-2917. PubMed ID: 32284334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
    Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS
    Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.
    Muñoz-Cobo B; Giménez E; Solano C; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Navarro D
    J Med Virol; 2014 May; 86(5):806-11. PubMed ID: 24105728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.
    Foley B; Cooley S; Verneris MR; Curtsinger J; Luo X; Waller EK; Anasetti C; Weisdorf D; Miller JS
    J Immunol; 2012 Nov; 189(10):5082-8. PubMed ID: 23077239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.
    Muñoz-Cobo B; Solano C; Benet I; Costa E; Remigia MJ; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Bravo D; Clari MÁ; Navarro D
    J Med Virol; 2012 Feb; 84(2):259-67. PubMed ID: 22170546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells.
    Djaoud Z; Riou R; Gavlovsky PJ; Mehlal S; Bressollette C; Gérard N; Gagne K; Charreau B; Retière C
    J Innate Immun; 2016; 8(4):374-85. PubMed ID: 27116381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of Cytomegalovirus-induced NKG2C+ Natural Killer Cells in the Lung Allograft.
    Harpur CM; Stankovic S; Kanagarajah A; Widjaja JML; Levvey BJ; Cristiano Y; Snell GI; Brooks AG; Westall GP; Sullivan LC
    Transplantation; 2019 Aug; 103(8):1689-1699. PubMed ID: 30461721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation.
    Yu XX; Shang QN; Liu XF; He M; Pei XY; Mo XD; Lv M; Han TT; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Zhao XY; Huang XJ
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34990406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
    Lopez-Vergès S; Milush JM; Schwartz BS; Pando MJ; Jarjoura J; York VA; Houchins JP; Miller S; Kang SM; Norris PJ; Nixon DF; Lanier LL
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14725-32. PubMed ID: 21825173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus.
    Ariyanto IA; Estiasari R; Edwar L; Makwana N; Lee S; Price P
    Immunol Invest; 2019 May; 48(4):345-354. PubMed ID: 30422022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT.
    van der Ploeg K; Sottile R; Kontopoulos T; Shaffer BC; Papanicolaou GA; Maloy MA; Cho C; Robinson KS; Perales MA; Le Luduec JB; Hsu KC
    Blood Adv; 2023 Oct; 7(19):5784-5798. PubMed ID: 37196646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.